NON-SPECIFIC CONGENITAL CONNECTIVE TISSUE DISORDERS AS AN INDEPENDENT PREDICTOR OF STRUCTURAL AND FUNCTIONAL ARTERIAL CHANGES

Aim. To assess the impact of non-specific congenital connective tissue disorders (CCTD) on the changes in arterial stiffness and endothelial function; to study the role of CCTD as an independent predictor of structural and functional arterial changes.

Material and methods. The study included 147 18–50-year-old men and women with CCTD and 85 healthy volunteers, comparable by age and gender (controls). All participants underwent a screening assessment of cardiovascular risk factors (RFs) and the assessment of heart rate variability (HRV), pulse wave velocity (PWV) at baseline (PWVbas) and after sublingual administration of nitroglycerin (PWVntg), and endothelium-dependent vasodilatation (EDVD), assessed by photopletismography.

Results. Compared to the control group, CCTD patients had lower values of body mass index (p<0,001), waist circumference, WC (p<0,001), hip circumference, HC (p<0,001), WC/HC ratio (p<0,005), systolic blood pressure (p<0,05), total cholesterol (p<0,001), low-density lipoprotein cholesterol (p<0,005), atherogenicity index (p<0,05), and triglycerides (p<0,005). Moreover, CCTD patients were characterized by sympathetic activation, increased PWVbas (p<0,001), PWVntg (p<0,05), and EDVD (p<0,001). According to the results of stepwise multivariate analyses of the whole sample data, CCTD was a significant independent predictor of PWVbas (p<0,001), PWVntg (p<0,005), and EDVD (p<0,005 and <0,05 in men and women, respectively).

Conclusion. Patients with CCTD demonstrated increased arterial stiffness and endothelium-dependent vasodilatation, compared to healthy controls. Independently from cardiovascular RFs and autonomic dysregulation, CCTD is a significant predictor of structural and functional arterial changes and can also have a prognostic value. These findings should be taken into account in the studies which assess vascular parameters.

1. Cohn JN, Quyyumi AA, Hollenberg NK, et al. Surrogate markers for cardiovascular disease: functional markers. Circulation. 2004; 29 (109): IV31–46.

2. Nechaeva GI, Viktorova IA, Druk IV. Connective tissue dysplasia: prevalence, phenotypic features, association with other diseases. Doctor 2006; 1: 19–23. Russian (Нечаева Г. И., Викторова И.А, Друк И. В. Дисплазия соединитель- ной ткани: распространенность, фенотипические признаки, ассоциации с другими заболеваниями. Врач 2006; 1: 19–23.)

3. Mattace-Raso FU, Vander-Cammen TJ, Hofman A, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation 2006; 113 (5): 657–63.

4. Landmesser U, Hornig B, Drexler H. Endothelial Function: A Critical Determinant in Atherosclerosis? Circulation 2004; 109: 27–33.

5. Laurent S, Boutouyrie P, Lacolley P. Structural and genetic bases of arterial stiffness. Hypertension 2005; 45 (6): 1050–5.

6. Hereditary disorders of connective tissue. Russian recommendations. Moscow 2012; 49 p. Russian (Наследственные нарушения соедини- тельной ткани. Российские рекомендации. Москва 2012; 49 c).

7. Yabluchansky NI, Martinenko AV. Heart rate variability in aid of the practitioner. Kharkov: KNU 2010; 131p. Russian (Яблучанский Н. И., Мартыненко А. В. Вариабельность сердечного ритма в помощь пра- ктическому врачу. Харьков: КНУ 2010; 131 с).

8. Semenkin AA, Novikov AI, Protskii IA, et al. Detection of structural changes of large arteries by characteristics of peripheral pulse wave: comparison with high resolution ultrasonic investigation. Therapeutic archives 2007; 79 (9): 54–9. Russian (Семенкин А. А., Новиков А. И., Процкий И. А. и др. Метод опреде- ления структурных сосудистых изменений крупных артерий по характери- стикам периферической пульсовой волны: сравнение с ультразвуковым исследованием высокого разрешения. Тер архив 2007; 79 (9): 54–9).

9. Wilkinson IB, Hall IR, MacCallum H, et al. Clinical Evaluation of a Noninvasive, Widely Applicable Method for Assessing Endothelial Function. Arterioscler Thromb Vasc Biol 2002; 22: 147–52.

10. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, Pathophysiology, and Therapy of Arterial Stiffness. Arterioscler Thromb Vasc Biol 2005; 25: 932–43

11. Swierblewska E, Hering D, Kara T, et al. An independent relationship between muscle sympathetic nerve activity and pulse wave velocity in normal humans. J Hypertension 2010; 28 (5): 979–84.

12. Semyonkin AA, Drokina OV, Konev VP, et al. Structural-functional changes of arteries in young patients with undifferentiated connective tissue dysplasia. The Siberian medical journal 2011; 26 (3): 66–71. Russian (Семенкин А. А., Дрокина О. В., Конев В. П. и др. Структурно- функциональные изменения артерий у лиц молодого возраста с недифференцированной дисплазией соединительной ткани. Сибирский медицинский журнал 2011; 26 (3): 66–71).

13. Wilkinson IB, Franklin SS, Cockcroft JR. Nitric oxide and the regulation of large artery stiffness: from physiology to pharmacology. Hypertension 2004; 44 (2): 112–6.

14. Brillante DG, O’Sullivan AJ, Johnstone MT, et al. Arterial stiffness and haemodynamic response to vasoactive medication in subjects with insulin￾resistance syndrome. Clin Sci 2008; 114 (2): 139–47.

15. Traub O, Berk BC. Laminar shear stress: mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler Thromb Vasc Biol 1998; 18 (5): 677–85.